Stone, KidneyALURNCT06793540
Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy.
A study testing SELF POSTUROTHERAPIE in people with Stone, Kidney, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 2 sites in France.
Trial summary
The main objective of this study is to evaluate the effectiveness of an auto posturotherapy technique on the RFS at three months of patients treated for lower calyceal urinary stones by extracorporeal lithotripsy (ECL) or retrograde flexible ureteroscopy. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Stone, Kidney
- What is being tested?
- SELF POSTUROTHERAPIE
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 216 participants
- Where
- 2 sitesFrance
- Study dates
- 30 Jun 2025to May 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
None listed.
Who cannot join
- Patients presenting one of the following criteria will not be included in the study:
- Renal or ureteral malformation: ureteral stenosis, pyelo-ureteral junction syndrome, horseshoe kidney, para calyceal diverticulum, pelvic kidney.
- LEC session interrupted due to treatment intolerance
- Physical disability making posturotherapy impossible (particularly spinal, etc.), morbid obesity, major gastroesophageal reflux, heart or respiratory failure.
- Balance disorder which would not allow self-posturotherapy to be carried out alone.
- Patient under legal protection, under guardianship or under curatorship
Show all 13Show fewer
- Posturotherapy carried out while wearing a JJ probe
- Posturotherapy carried out by a third party (physiotherapist or other)
- Pregnant or breastfeeding patient
- Patient not affiliated to the French social security system
- Impossibility of providing the subject with informed information and/or giving written informed consent: dementia, psychosis, disorders of consciousness, non-French speaking patient
- Treatment that may modify the clearance of fragments (beta blocker, diuretic, etc.)
- Patient included in another therapeutic study protocol
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
France2 sites, 2 recruiting
- Recruiting
Hôpital Edouard Herriot -
Lyon, 69003
Nadia ABID -, Dr, 04 72 11 80 88, nadia.abid@chu-lyon.fr
- Recruiting
Clinique La Croix du Sud
Quint-Fonsegrives, 31130
Christophe ALMERAS, Dr, 05 36 28 00 00 ext. +33, c.almeras@gmail.com
Christophe ALMERAS, Dr
About this study
The main objective of this study is to evaluate the effectiveness of an auto posturotherapy technique on the RFS at three months of patients treated for lower calyceal urinary stones by extracorporeal lithotripsy (ECL) or retrograde flexible ureteroscopy.
- Conditions
- Stone, Kidney
- Being tested
- SELF POSTUROTHERAPIE
- Medical subject headings
- Kidney Calculi
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SELF POSTUROTHERAPIEBehavioural
a simplified posturotherapy protocol that can be carried out by the patient himself. This protocol is based on the same principles as posturotherapy carried out by a physiotherapist by combining inclined positioning, percussion and diuresis.
| Study group | Role | What they receive |
|---|---|---|
| self-posturotherapy | Experimental | standard care (according to recommendations) + self-posturotherapy program Receives: Behavioral: SELF POSTUROTHERAPIE |
| Standard care | No intervention | standard care alone (according to recommendations) |
What is being measured
The primary outcome is the main question the study is designed to answer.
stone free rate
Measured: 3 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jan 2025
- Study start30 Jun 2025
- Primary completionMay 2027 (estimated)
- Study completionMay 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stone, KidneyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Model Description
- Masking
- None (open label)
- Enrolment
- 216 participants (estimated)
Sponsor and investigators
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06793540
- Sponsor's protocol ID
- 2023-06-024-ALMERAS(ALUR)
- Other IDs
- 2024-A02267-40
- Acronym
- ALUR
- Status last verified
- Jul 2025
- First submitted
- 20 Jan 2025
- Last updated
- 8 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No